The Relationship Between Serum Adipokine Fibroblast Growth Factor-21 and Gestational Diabetes Mellitus

Overview

Journal J Diabetes Investig

Specialty Endocrinology

Date 2022 Jul 24

PMID 35871469

Authors

Xiaojiao Jia

Liwei Bai

Ning Ma

Qiang Lu

Affiliations

Soon will be listed here.

Abstract

Aims/introduction: To explore the differences of serum fibroblast growth factor-21 (FGF-21) levels in pregnant women with normal glucose tolerance and gestational diabetes mellitus (GDM), and to analyze the relationship between FGF-21 and glucose and lipid metabolic indicators, leptin, retinol binding protein 4 (RBP-4) and adiponectin in GDM, in order to provide basis for the prevention and treatment of GDM.

Materials And Methods: Total of 120 women were included, and divided into normal glucose tolerance group (58 cases) and GDM group (62 cases) according to the 75 g oral glucose tolerance test results. General information were recorded; height, weight and blood pressure, blood glucose, lipids, insulin, FGF-21, leptin, RMP-4, and adiponectin were measured, and body mass index (BMI), homeostasis model assessment-IR, homeostasis model assessment-β and area under glucose curve were calculated. The t-test, Pearson analysis and multiple linear regression analysis were used to evaluate the differences and related factors of FGF-21 in GDM.

Results: The pre-pregnancy BMI, pregnancy BMI, weight gain during pregnancy and FGF-21 levels were higher in GDM group, whereas there were no statistically significant differences in leptin, RBP-4 and adiponectin. Correlation analysis suggested that FGF-21 level was correlated with age, pre-pregnancy BMI, weight gain during pregnancy, high-density lipoprotein cholesterol, leptin, RBP-4 and adiponectin, and the results of multiple linear regression showed that serum FGF-21 was related to pre-pregnancy BMI, weight gain during pregnancy, leptin, RBP-4 and adiponectin in GDM.

Conclusions: There were higher serum FGF-21 levels in GDM, which might be related to pre-pregnancy BMI, weight gain during pregnancy, leptin, RBP-4 and adiponectin.

Citing Articles

Circulating fibroblast growth factor 21 levels in gestational diabetes mellitus and preeclampsia: a systematic review and meta-analysis.

Cao Z, Deng Z, Lu J, Yuan Y BMC Pregnancy Childbirth. 2025; 25(1):34.

PMID: 39819596 PMC: 11740615. DOI: 10.1186/s12884-025-07157-3.

Retinol-binding protein 4 (RBP4) circulating levels and gestational diabetes mellitus: a systematic review and meta-analysis.

Leca B, Kite C, Lagojda L, Davasgaium A, Dallaway A, Chatha K Front Public Health. 2024; 12:1348970.

PMID: 38532976 PMC: 10964926. DOI: 10.3389/fpubh.2024.1348970.

The Role of the FGF19 Family in the Pathogenesis of Gestational Diabetes: A Narrative Review.

Sadowska A, Poniedzialek-Czajkowska E, Mierzynski R Int J Mol Sci. 2023; 24(24).

PMID: 38139126 PMC: 10743406. DOI: 10.3390/ijms242417298.

A positive association of serum CCN5/WISP2 levels with the risk of developing gestational diabetes mellitus: a case-control study.

Hamdan Alshganbee M, Nabatchian F, Farrokhi V, Fadaei R, Moradi N, Afrisham R J Physiol Sci. 2023; 73(1):22.

PMID: 37794318 PMC: 10717677. DOI: 10.1186/s12576-023-00879-z.

Adipokines in Pregnancy: A Systematic Review of Clinical Data.

Kabbani N, Bluher M, Stepan H, Stumvoll M, Ebert T, Tonjes A Biomedicines. 2023; 11(5).

PMID: 37239090 PMC: 10216846. DOI: 10.3390/biomedicines11051419.

References

Wang Z, Yuan M, Xu C, Zhang Y, Ying C, Xiao X . FGF21 Serum Levels in the Early Second Trimester Are Positively Correlated With the Risk of Subsequent Gestational Diabetes Mellitus: A Propensity-Matched Nested Case-Control Study. Front Endocrinol (Lausanne). 2021; 12:630287. PMC: 8113961. DOI: 10.3389/fendo.2021.630287. View

Stein S, Stepan H, Kratzsch J, Verlohren M, Verlohren H, Drynda K . Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia. Metabolism. 2009; 59(1):33-7. DOI: 10.1016/j.metabol.2009.07.003. View

Farabi S, Hernandez T . Low-Carbohydrate Diets for Gestational Diabetes. Nutrients. 2019; 11(8). PMC: 6723585. DOI: 10.3390/nu11081737. View

Paz-Filho G, Mastronardi C, Licinio J . Leptin treatment: facts and expectations. Metabolism. 2014; 64(1):146-56. DOI: 10.1016/j.metabol.2014.07.014. View

Bluher M, Mantzoros C . From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century. Metabolism. 2014; 64(1):131-45. DOI: 10.1016/j.metabol.2014.10.016. View

Bonakdaran S, Khorasani Z, Jafarzadeh F . INCREASED SERUM LEVEL OF FGF21 IN GESTATIONAL DIABETES MELLITUS. Acta Endocrinol (Buchar). 2019; 13(3):278-281. PMC: 6516566. DOI: 10.4183/aeb.2017.278. View

Johns E, Denison F, Norman J, Reynolds R . Gestational Diabetes Mellitus: Mechanisms, Treatment, and Complications. Trends Endocrinol Metab. 2018; 29(11):743-754. DOI: 10.1016/j.tem.2018.09.004. View

Metzger B, Persson B, Lowe L, Dyer A, Cruickshank J, Deerochanawong C . Hyperglycemia and adverse pregnancy outcome study: neonatal glycemia. Pediatrics. 2010; 126(6):e1545-52. DOI: 10.1542/peds.2009-2257. View

Lende M, Rijhsinghani A . Gestational Diabetes: Overview with Emphasis on Medical Management. Int J Environ Res Public Health. 2020; 17(24). PMC: 7767324. DOI: 10.3390/ijerph17249573. View

10.

Mallardo M, Ferraro S, Daniele A, Nigro E . GDM-complicated pregnancies: focus on adipokines. Mol Biol Rep. 2021; 48(12):8171-8180. PMC: 8604848. DOI: 10.1007/s11033-021-06785-0. View

11.

Yuan D, Wu B, Henry A, Rye K, Ong K . Role of fibroblast growth factor 21 in gestational diabetes mellitus: A mini-review. Clin Endocrinol (Oxf). 2018; 90(1):47-55. DOI: 10.1111/cen.13881. View

12.

Barbour L, Hernandez T . Maternal Non-glycemic Contributors to Fetal Growth in Obesity and Gestational Diabetes: Spotlight on Lipids. Curr Diab Rep. 2018; 18(6):37. DOI: 10.1007/s11892-018-1008-2. View

13.

Badman M, Koester A, Flier J, Kharitonenkov A, Maratos-Flier E . Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis. Endocrinology. 2009; 150(11):4931-40. PMC: 2775979. DOI: 10.1210/en.2009-0532. View

14.

McIntyre H, Catalano P, Zhang C, Desoye G, Mathiesen E, Damm P . Gestational diabetes mellitus. Nat Rev Dis Primers. 2019; 5(1):47. DOI: 10.1038/s41572-019-0098-8. View

15.

Bai Y, Tang L, Li L . The roles of ADIPOQ rs266729 and MTNR1B rs10830963 polymorphisms in patients with gestational diabetes mellitus: A meta-analysis. Gene. 2019; 730:144302. DOI: 10.1016/j.gene.2019.144302. View

16.

Perez-Perez A, Vilarino-Garcia T, Guadix P, Duenas J, Sanchez-Margalet V . Leptin and Nutrition in Gestational Diabetes. Nutrients. 2020; 12(7). PMC: 7400219. DOI: 10.3390/nu12071970. View

17.

Howell K, Powell T . Effects of maternal obesity on placental function and fetal development. Reproduction. 2016; 153(3):R97-R108. PMC: 5432127. DOI: 10.1530/REP-16-0495. View

18.

Estienne A, Bongrani A, Reverchon M, Rame C, Ducluzeau P, Froment P . Involvement of Novel Adipokines, Chemerin, Visfatin, Resistin and Apelin in Reproductive Functions in Normal and Pathological Conditions in Humans and Animal Models. Int J Mol Sci. 2019; 20(18). PMC: 6769682. DOI: 10.3390/ijms20184431. View

19.

Jia J, Wei W, Yu F, Liu R, Shen Y, Zhang R . Circulating levels of fibroblast growth factor 21 in gestational diabetes mellitus: a meta-analysis. Endocr J. 2020; 68(3):345-352. DOI: 10.1507/endocrj.EJ20-0481. View

20.

Nitert M, Barrett H, Kubala M, Scholz Romero K, Denny K, Woodruff T . Increased placental expression of fibroblast growth factor 21 in gestational diabetes mellitus. J Clin Endocrinol Metab. 2014; 99(4):E591-8. DOI: 10.1210/jc.2013-2581. View